For over a decade, LSX Europe has brought together the leaders shaping the future of life sciences - and in 2026, we take the Congress to Lisbon for the very first time. It unites the founders and CEOs of early to late stage biotechs, medtechs and healthtechs with global investors, pharma and the partners driving innovation forward.
See who’s already joining us in 2026: https://informaconnect.com/lsx-world-congress/2026-attendees/
Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease.
The future is coming. A future enabled and enriched by the incredible power of machine learning. A future in which diseases are curtailed or cured starting with better and faster drug discovery.
At Mestag we truly believe in our values and live by them every day. We’re ambitious about our science and its potential to deliver meaningful therapeutics to the patients that need them most. We believe in a culture of diversity, equality and investing in people to ensure our talented and passionate team members can fulfil their full potential.
We are now transitioning our lead programme into clinic - There has never been a better time to join #TeamMestag
The Director, Global Market Research will help establish BioNTech’s Global commercial market research capabilities for its multiple upcoming global launches in Oncology. You will be part of the best-in-class high-performing team with great visibility to the senior leadership.
Your main taks are:
PRIMARY OBJECTIVES: The Business Development Manager/Senior Manager is a fast-paced, dynamic role, responsible for identifying and developing new opportunities within our Translational Oncology Solutions offering. The BD Manager/Senior Manager will work closely with commercial, marketing, R&D and operations teams to lead business development efforts across the UK/Nordic Region territory. The ideal candidate will have a firm understanding of oncology research and market dynamics.
Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease.
The future is coming. A future enabled and enriched by the incredible power of machine learning. A future in which diseases are curtailed or cured starting with better and faster drug discovery.
For 25 years, Isogenica has built deep expertise and knowledge about how to find small-format VHH antibodies (around 1/10th the size of an IgG) and peptides and develop them into drugs in partnership with some of the world’s most innovative biopharma companies.
As an Antibody Discovery Scientist, you will deliver VHH and peptide discovery projects for our partners for use in diverse applications, helping to bring new medicines, diagnostics tools, and other cutting-edge solutions to the world and improve patient lives.
MicroGravity: Just Another Research Environment is an event to help the Life Science sector and explore the value and opportunity from
|
|
The United Kingdom Health Security Agency (UKHSA) is a system leader for health security; taking action internationally to strengthen global health security, providing trusted advice to government and the public and reducing inequalities in the way different communities experience and are impacted by infectious disease, environmental hazards, and other threats to health.
Tony Jones